Abstract TH910: Examining the Associations Between Social Vulnerability and Clinical and Behavioral Risk for Atherosclerotic Cardiovascular Disease among Women with HIV and Women without HIV

J Jenni Wise (University of Alabama at Birmingham, Birmingham, Alabama, United States) L Liang Shan (Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St.) J Jessica Blair (University of Alabama at Birmingham, Columbiana, Alabama, United States) E Emily Levitan (UNIVERSITY ALABAMA AT BIRMINGHAM, Birmingham, Alabama, United States) E Elizabeth Jackson (University of Alabama at Birmingham, Birmingham, Alabama, United States) P Paul Muntner (Perisphere real world evidence, Austin, Texas, United States) E Edgar Overton (ViiV Healthcare North America Medical Affairs, Durham, North Carolina, United States) A Andrew Edmonds (University North Carolina Chapel Hill, Chapel Hill, North Carolina, United States) M Maria Alcaide (University of Miami, Miami, Florida, United States) D David Hanna S Seble Kassaye (Georgetown university, DC, District of Columbia, United States) A Aruna Chandran (Johns Hopkins University, Baltimore, Maryland, United States) S Sheri Weiser (University of California Center for Climate, Health, and Equity and Department of Medicine, University of California, San Francisco, San Francisco) G Gina Wingood T Tracey Wilson D Deborah Konkle-Parker K kathleen weber (Hektoen Institute of Medicine, Chicago, Illinois, United States) M Mirjam-Colette Kempf (University of Alabama at Birmingham, Birmingham, Alabama, United States)

Abstract

Introduction: The Social Vulnerability Index (SVI) is used to assess area-level atherosclerotic cardiovascular disease (ASCVD) risk by identifying communities that are more susceptible to ASCVD due to exposure to adverse social and environmental factors and their associated behavioral and clinical risks. We sought to examine associations of overall SVI score and its thematic elements with clinical (hypertension, diabetes, and dyslipidemia) and behavior (smoking, substance, and heavy alcohol use) risk for ASCVD and estimated 10-year ASCVD risk, as calculated by the ACC/AHA Pooled Cohort Equation. Methods: Women with HIV (WWH) and women without HIV (WWoH) from the MACS/WIHS Combined Cohort Study were included if they were 30–79 years of age, had residential location data available, and attended a study visit between April and September 2019. Addresses were geocoded to 2019 census tract-level SVI. Analyses incorporated both the overall SVI score and its four thematic elements: socioeconomic status, household composition, racial and ethnic minority status, and housing type and transportation. Participants were grouped into tertiles by their SVI, with the third tertile representing those with higher relative vulnerability. Logistic regression models were used to examine the associations between participant tertiles for SVI and clinical and behavior risk factors for ASCVD and 10-year risk scores. Models were adjusted for HIV-status, age, race/ethnicity, employment, income, and insurance, except when modeling 10-year risk, age was removed as a covariate. Results: The analyses included 1699 women (72% WWH). The majority (88%) were virally suppressed. Clinical risk factors for ASCVD were prevalent [(hypertension (73%), diabetes (30%), dyslipidemia (54%)]. Few (<10%) reported substance use or heavy alcohol use and 40% reported smoking. Compared to women in the first SVI tertile, women in third tertile had higher odds of diabetes (OR=1.35, 95% CI: 1.02 – 1.77) and lower odds of substance use (OR=0.73, 95% CI: 0.46 – 1.16) and heavy alcohol use (OR=0.84, 95% CI: 0.55 – 1.27). Women in the third tertile for racial and ethnic minority status had lower odds of hypertension (OR=0.71, 95% CI: 0.53 – 0.94). No other notable associations were present between overall SVI or its thematic elements and behavioral or clinical risk for ASCVD. Conclusion: The SVI may be useful in examining and addressing the impact of area-level social vulnerability on ASCVD risk among WWH and WWoH.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue Suppl_1
Published March 24, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (18)

J

Jenni Wise

University of Alabama at Birmingham, Birmingham, Alabama, United States

L

Liang Shan

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St.

J

Jessica Blair

University of Alabama at Birmingham, Columbiana, Alabama, United States

E

Emily Levitan

UNIVERSITY ALABAMA AT BIRMINGHAM, Birmingham, Alabama, United States

E

Elizabeth Jackson

University of Alabama at Birmingham, Birmingham, Alabama, United States

P

Paul Muntner

Perisphere real world evidence, Austin, Texas, United States

E

Edgar Overton

ViiV Healthcare North America Medical Affairs, Durham, North Carolina, United States

A

Andrew Edmonds

University North Carolina Chapel Hill, Chapel Hill, North Carolina, United States

M

Maria Alcaide

University of Miami, Miami, Florida, United States

D

David Hanna

S

Seble Kassaye

Georgetown university, DC, District of Columbia, United States

A

Aruna Chandran

Johns Hopkins University, Baltimore, Maryland, United States

S

Sheri Weiser

University of California Center for Climate, Health, and Equity and Department of Medicine, University of California, San Francisco, San Francisco

G

Gina Wingood

T

Tracey Wilson

D

Deborah Konkle-Parker

K

kathleen weber

Hektoen Institute of Medicine, Chicago, Illinois, United States

M

Mirjam-Colette Kempf

University of Alabama at Birmingham, Birmingham, Alabama, United States